Amicus Therapeutics Announces Full-Year 2012 Financial Results and Corporate Updates

[at noodls] – CHART Programs Advancing in Lysosomal Storage Diseases 12-Month Results from Ongoing Phase 3 Fabry Disease Monotherapy Study Expected 3Q13 CRANBURY, N.J., March 12, 2013 (GLOBE NEWSWIRE) — Amicus Therapeutics … more

View todays social media effects on FOLD

View the latest stocks trending across Twitter. Click to view dashboard

See who Amicus is hiring next, click here to view